Age <40 years is an independent prognostic factor predicting inferior overall survival in patients treated with breast conservative therapy

Breast Journal

Volumn 17, Issue 1, 2011, Pages 75-78

  Kim, Kyubo ^a   Chie, Eui Kyu ^a   Han, Wonshik ^a   Noh, Dong Young ^a   Oh, Do Youn ^a   Im, Seock Ah ^a   Kim, Tae You ^a   Bang, Yung Jue ^a   Ha, Sung W ^a  

^a Seoul National University   (South Korea)

Author keywords

age; breast cancer; breast conservative therapy; prognostic factor

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CONSERVATIVE THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISTANT METASTASIS; EARLY CANCER; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PROGNOSIS; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; SYSTEMIC THERAPY; TUMOR VOLUME; ADJUVANT THERAPY; AGE; BREAST TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; LYMPHADENECTOMY; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SEGMENTAL MASTECTOMY; SOUTH KOREA; TUMOR RECURRENCE;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RECEPTORS, ESTROGEN; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 79251529544     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.01021.x     Document Type: Article

References (20)

1. Zhou P, Recht A,. Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 2004; 101: 1264-74.
2. Hankey BF, Miller B, Curtis R, Kosary C,. Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 1994; 16: 7-14.
3. Ministry of Health and Welfare. 2002 Annual Report of the Korea Central Cancer Registry. Seoul: Ministry of Health and Welfare, 2003.
4. Foo CS, Su D, Chong CK, et al. Breast cancer in young Asian women: study on survival. ANZ J Surg 2005; 75: 566-72.
5. Cheng SH, Tsou MH, Liu MC, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 2000; 63: 213-23.
6. Han W, Kim SW, Park IA, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 2004; 4: 82-9.
7. Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences after breast conserving therapy more frequent in young patients? J Clin Oncol 1990; 8: 591-8.
8. Elkhuizen PH, Vijver M, Hermans J, Zonderland HM, Velde CJ, Leer JW,. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998; 40: 859-67.
9. Vrieling C, Collette L, Fourquet A, et al. Can patient-, treatment-, and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 2003; 39: 932-44.
10. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000; 18: 2817-27.
11. Zellars RC, Hilsenbeck SG, Clark GM, et al. Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients. J Clin Oncol 2000; 18: 1906-13.
12. Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12: 888-94. (Pubitemid 24145313)
13. Bonnier P, Romain S, Charpin C, et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 1995; 62: 138-44.
14. Coulombe G, Tyldesley S, Speers C, et al. Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 2007; 67: 1282-90.
15. Solin LJ, Fowble B, Schultz DJ, Goodman RL,. Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phy 1989; 16: 373-81.
16. Recht A, Connolly JL, Schnitt SJ, et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1988; 14: 3-10.
17. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001; 196: 1688-97.
18. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M,. Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 2000; 320: 474-9.
19. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005; 365: 1687-717.
20. Beadle BM, Woodward WA, Tucker SL, et al. Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 2009; 73: 734-44.